Search Results - K. I. Zhordania
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
Early ovarian cancer: our view of the problem by K. I. Zhordania, S. V. Khokhlova
Published 2014-08-01The paper considers some pathogenetic aspects of ovarian tumor development, on the basis of which the authors recommend to perform more aggressive chemotherapy in patients with the so-called early stages of ovarian cancer.
Get full text
Article -
2
Clinical and histological features of purely stromal cell ovarian tumors by A. M. Beishembaev, K. I. Zhordania
Published 2020-01-01Aim: to identify clinical and histologic features of pure stromal ovarian tumors.Materials and methods. We analyzed the clinical data from patients treated and followed up at the Blokhin National Medical Research Center of Oncology and the National Center of Oncology and Hematology of the Kyrgyz Rep...
Get full text
Article -
3
ARTIFICIAL MENOPAUSE AND EXPERIENCE OF CIMICIFUGA EXTRACT USE (KLIMADYNON) by Yu. G. Payanidi, K. I. Zhordania
Published 2014-09-01Advances made in oncogynecology and improvements of surgical, radiation, and drug treatment provided relatively good sur- vival rates in patients with female genital organ lesions. However, this treatment often leads to postcastration syndrome mani- festations in most young women. New rehabilitation...
Get full text
Article -
4
Clinical and histological criteria for sex cord ovarian stromal tumors by A. М. Beishembaev, K. I. Zhordania
Published 2020-09-01Aim: to identify clinical and histological criteria for sex cord ovarian stromal tumors (OSTs).Materials and Methods. The retrospective non-comparative study was based on the main inclusion such as histologically verified sex cord OSTs. A standard examination algorithm was analyzed (ultrasound, bloo...
Get full text
Article -
5
Quantification analysis of the expression of tumor-associated proteins in serum samples from patients with ovarian cancer and those with other tumor location. Possibilities of thei... by T. S. Bobrova, Yu. V. Chuyev, K. I. Zhordania
Published 2014-07-01The specific features of the expression of tumor-associated proteins (TAP) were immunologically studied in the sera of patients with ovarian cancer (OC) and other tumor location by means of immune sera (As) or monoclonal antibodies (MAb) to find out whether they could be used to diagnose and estimat...
Get full text
Article -
6
EXPRESSION OF THE TUMOR-ASSOCIATED PROTEINS IN THE OVARIAN CANCER by T. S. Bobrova, K. I. Zhordania, Yu. V. Chuyev
Published 2014-09-01With the help of monoclonal antibodies (MCA-1, MCA-3, G1 class immunoglobulins) and polyspecific antiserum (As) by means of immunoblotting (IB) the increase of the expression of the tumor-associated proteins (TAP) in the samples of the tumor tissues (in 94, 55 and 38% respectively), metastatic lymph...
Get full text
Article -
7
IMMUNOPROPHYLAXIS OF CANCER OF THE CERVIX UTERI by V. P. Kozachenko, G. Z. Chkagua, K. I. Zhordania, Yu. G. Payanidi
Published 2014-09-01The prevention of cancer of the cervix uteri (CCU) is an interdisciplinary problem that may be solved only via joint efforts of gynecol- ogists, oncologists, virologists, and immunologists. Since there is currently strong evidence for the viral origin of CCU, vaccination is prominent in its primary....
Get full text
Article -
8
Possibilities of rehabilitation in cancer patients to preserve their reproductive function by L. V. Adamyan, K. I. Zhordania, Yu. G. Payanidi, E. G. Tjirsina
Published 2014-08-01Social rehabilitation in patients who have been treated for malignancies of different sites and stages becomes a particularly urgent problem today and its solution is one of the promising areas of oncology. The important stage of this rehabilitation that seems to us is to maintain or recover their r...
Get full text
Article -
9
Adenosquamous cell carcinoma of the cervix — clinical and prognostic characteristics of the disease by E. K. Tanriverdieva, K. I. Zhordania, T. I. Zakharova, E. V. Prihodko, L. T. Mamedova
Published 2014-07-01Adenosquamous cell carcinoma of the cervix is a rare form of cancer of the cervix. Because of the small number of observations adenosquamous cell carcinoma of the cervix remains poorly understood disease, although the first mention of it dates back to 1956, when A. Glucksmann, and C.D. Cherry first...
Get full text
Article -
10
RARE FORMS OF UTERINE LEIOMYOMAS (description of a case) by Yu. G. Payanidi, K. I. Zhordania, I. S. Stilidi, T. I. Zakharova, V. Yu. Bokhyan
Published 2017-03-01Leiomyomas predominate among benign nonepithelial tumors of the corpus uteri. Leiomyoma is commonly an asymptomatic tumor and detectable in most cases at routine gynecological examinations. However, some forms of leiomyomas have a definite metastatic potential and, despite its benign morphological s...
Get full text
Article -
11
Uterine leiomyomas and metastases: description of a case by T. I. Zakharova, Yu. G. Payanidi, K. I. Zhordania, N. I. Lazareva, E. V. Korzhevskaya
Published 2014-08-01Leiomyomas predominate among benign nonepithelial tumors of the corpus uteri. According to the data available in the literature, they occur in 25% of women above 35 years of age and constitute 33% of all gynecological diseases. Leimyoma is commonly an asymptomatic tumor and detectable in most cases...
Get full text
Article -
12
Proteomics in the diagnosis of ovarian cancer by V. E. Shevchenko, N. E. Arnotskaya, D. E. Makarov, N. R. Pogosyan, K. I. Zhordania
Published 2014-07-01Proteomics has recently found wide application to account for the molecular mechanisms of cancer and to search for biomarkers that may be used to diagnose and/or predict the development of the disease. The paper briefly reviews proteomic studies to detect ovarian cancer biomarkers, by taking into ac...
Get full text
Article -
13
Ovarian carcinosarcoma (a literature review) by A. M. Beishembaev, K. I. Zhordania, E. D. Choi, A. A. Turkmenov, A. K. Moldobekova
Published 2022-11-01Introduction. Despite that ovarian carcinosarcoma (OCS) is an extremely rare disease, it is of great medical and social importance by taking into account very high level of overall mortality, recurrence, metastasis, and economic costs.Aim: to summarize current data on various aspects of OCS.Material...
Get full text
Article -
14
Use of inhibin B in recurrent ovarian granulosa cell tumors by A. M. Beishembayev, N. V. Lyubimova, V. M. Abayev, K. I. Zhordania, V. A. Khailenko
Published 2014-08-01Early diagnosis of recurrent ovarian granulose cell tumors (OGCT) remains an urgent problem of modern oncogynecology. Inhibin B is one of the most potentially important markers of OGCT. Nevertheless, in the world there are today only single studies evaluating the clinical value of inhibin B. The pap...
Get full text
Article -
15
Identification of proteomic markers for metastasis of ovarian cancer by V. E. Shevchenko, D. E. Makarov, S. V. Kovalev, N. E. Arnotskaya, N. R. Pogosyan, K. I. Zhordania
Published 2014-08-01The proteome of ascites and pleural fluids (AF and PF) was mapped in patients with ovarian cancer (OC). 240 and 190 proteins were identi- fied with a high degree of assurance in A F and PF, respectively . The major portion w as extracellular and membrane proteins, whi ch ac- counted for 45 and 49 %...
Get full text
Article -
16
Ovarian malignancies and polyneoplasias: clinical presentation, diagnosis, mechanisms of development, prognosis by P. Z. Kutalia, V. Yu. Selchuk, Yu. G. Payanidi, K. I. Zhordania, V. M. Shelepova, T. I. Zakharova
Published 2014-07-01The paper considers the clinical picture, diagnosis, mechanisms of development, and prognosis of ovarian malignancies and polyneoplasias in detail. The purpose of the investigation was to study the clinical features of polyneoplasms with the involvement of the ovaries and to define the ways of impro...
Get full text
Article -
17
Discovery of potential ovarian cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry by V. E. Shevchenko, N. E. Arnotskaya, E. V. Ogorodnikova, N. R. Pogosyan, A. N. Gritsay, K. I. Zhordania
Published 2014-07-01At present, there is no screening test for the early detecting and monitoring of ovarian cancer, one of the most lethal form of gynaecological malig- nancy in the worldwide. In this study, the new methodology for the search of tumor markers of ovarian cancer, involving profiling the low-molec- ular...
Get full text
Article -
18
The pathomorphological characteristics of clear-cell adenocarcinomas of the ovary and its mixed tumors with a clear-cell component by M.. D Akhmedova, M. A. Shabanov, V. V. Barinov, K. I. Zhordania, L. I. Bokina, E. A. Mustafina
Published 2014-07-01Objective: to study the pathomorphological signs of pure and mixed clear-cell ovarian tumors with a clear-cell component.Subjects and methods. The clinical and morphological characteristics and the course of the disease were analyzed in 96 patients aged 21 to 75 years with clear-cell ovarian carcino...
Get full text
Article -
19
The first experience with intraabdominal chemotherapy in patients with disseminated ovarian cancer by A. S. Tyulyandina, V. Yu. Buidenok, K. I. Zhordania, I. V. Panichenko, V. V. Kuznetsov, M. B. Stenina, S. A. Tyulyandin
Published 2014-08-01Ovarian cancer (OC) is characterized by its late diagnosis, mainly local tumor dissemination within the abdomen and small pelvis, and a relatively high susceptibility to drug therapy . Intraabdominal chemotherapy (CT) allows the higher intraabdominal drug concentrations to be produced as compared to...
Get full text
Article -
20
RECURRENT OVARIAN GRANULOSA CELL TUMORS: DIAGNOSIS AND TREATMENT by A. M. Beishembayev, V. A. Khailenko, N. V. Lyubimova, Yu. G. Payanidi, O. A. Anurova, O. N. Streltsova, K. I. Zhordania
Published 2014-09-01Recurrent ovarian granulose cell tumors (OGCT) occur in 20-40% of cases. The low incidence of OGCT and the specific features of their clinical course highly hamper the study of the mechanisms of development of recurrences and the possibilities of timely detection of disease progression and the deter...
Get full text
Article